Engineering yeast for producing human glycoproteins: where are we now?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Future Microbiology

• Publication date

  2015-01-19

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.2217/fmb.14.104PMID 25598335PMCID PMC7617146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycoengineering of yeasts from the perspective of glycosylation efficiency.

  2014cited by this paper
• Sweet and Sour: The Impact of Differential Glycosylation in Cancer Cells Undergoing Epithelial–Mesenchymal Transition

  2014cited by this paper
• In vitro enzymatic treatment to remove O-linked mannose from intact glycoproteins

  2014cited by this paper
• Genentech's glyco-engineered antibody to succeed Rituxan

  2014cited by this paper
• The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris

  2013cited by this paper
• MUC1 immunotherapy is here to stay

  2013cited by this paper
• Production of sialylated O-linked glycans in Pichia pastoris.

  2013cited by this paper
• Characterization of the Pichia pastoris Protein-O-mannosyltransferase Gene Family

  2013cited by this paper
• PMT1 gene plays a major role in O-mannosylation of insulin precursor in Pichia pastoris.

  2013cited by this paper
• Expression of glycoproteins bearing complex human-like glycans with galactose terminal in Hansenula polymorpha

  2013cited by this paper
• A Combined System for Engineering Glycosylation Efficiency and Glycan Structure in Saccharomyces cerevisiae

  2012cited by this paper
• Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans

  2012cited by this paper
• Protein glycosylation control in mammalian cell culture: past precedents and contemporary prospects.

  2012cited by this paper
• Production of biopharmaceutical proteins by yeast

  2012cited by this paper
• Engineering Yarrowia lipolytica to Produce Glycoproteins Homogeneously Modified with the Universal Man3GlcNAc2 N-Glycan Core

  2012cited by this paper
• Identification of Novel α1,3-Galactosyltransferase and Elimination of α-Galactose-containing Glycans by Disruption of Multiple α-Galactosyltransferase Genes in Schizosaccharomyces pombe*

  2012cited by this paper
• A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes

  2012cited by this paper
• High abundance of Serine/Threonine-rich regions predicted to be hyper-O-glycosylated in the secretory proteins coded by eight fungal genomes

  2012cited by this paper
• Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris

  2012cited by this paper
• Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris.

  2012cited by this paper
• Marketing approval of mogamulizumab

  2012cited by this paper
• Vertebrate protein glycosylation: diversity, synthesis and function

  2012cited by this paper
• Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man8GlcNAc2 and Man5GlcNAc2

  2012cited by this paper
• Elimination of β-mannose glycan structures in Pichia pastoris.

  2011cited by this paper
• Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris

  2011cited by this paper
• Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

  2011cited by this paper
• Functional and genomic analyses of blocked protein O‐mannosylation in baker's yeast

  2011cited by this paper
• Identification and functional characterization of the HpALG11 and the HpRFT1 genes involved in N-linked glycosylation in the methylotrophic yeast Hansenula polymorpha.

  2010cited by this paper
• Biopharmaceutical benchmarks 2010

  2010cited by this paper
• Recombinant Glucocerebrosidase (Imiglucerase) as a Therapy for Gaucher Disease

  2010cited by this paper
• Essential Role of YlMPO1, a Novel Yarrowia lipolytica Homologue of Saccharomyces cerevisiae MNN4, in Mannosylphosphorylation of N- and O-Linked Glycans

  2010cited by this paper
• N- and O-linked oligosaccharides completely lack galactose residues in the gms1och1 mutant of Schizosaccharomyces pombe

  2010cited by this paper
• Glycosylation of Therapeutic Proteins

  2010cited by this paper
• Engineering of glycosylation in yeast and other fungi: current state and perspectives

  2010cited by this paper
• Carbohydrate analysis throughout the development of a protein therapeutic

  2009cited by this paper
• Glycans on influenza hemagglutinin affect receptor binding and immune response

  2009cited by this paper
• Protein O-mannosylation: conserved from bacteria to humans.

  2009cited by this paper
• Pharmacological significance of glycosylation in therapeutic proteins.

  2009cited by this paper
• Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene.

  2009cited by this paper
• Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins.

  2008cited by this paper
• Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology

  2008cited by this paper
• Engineering of mucin-type human glycoproteins in yeast cells

  2008cited by this paper
• Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.

  2008cited by this paper
• Glycoengineering of the methylotrophic yeast Hansenula polymorpha for the production of glycoproteins with trimannosyl core N-glycan by blocking core oligosaccharide assembly.

  2008cited by this paper
• Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines.

  2007cited by this paper
• Functional Characterization of the Hansenula polymorpha HOC1, OCH1, and OCR1 Genes as Members of the Yeast OCH1 Mannosyltransferase Family Involved in Protein Glycosylation*

  2006cited by this paper
• Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins

  2006cited by this paper
• A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity1

  2005cited by this paper
• Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1).

  2004cited by this paper
• Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose.

  2004cited by this paper
• Roles of N-linked glycans in the endoplasmic reticulum.

  2004cited by this paper
• Functional analysis of the ALG3 gene encoding the Dol-P-Man: Man5GlcNAc2-PP-Dol mannosyltransferase enzyme of P. pastoris.

  2004cited by this paper
• In Vivo Synthesis of Mammalian-Like, Hybrid-Type N-Glycans in Pichia pastoris

  2004cited by this paper
• Interaction of GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase with GDP-mannose-4,6-dehydratase stabilizes the enzyme activity for formation of GDP-fucose from GDP-mannose.

  2003cited by this paper
• Production of complex human glycoproteins in yeast.

  2003cited by this paper
• Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris

  2003cited by this paper
• Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein

  2002cited by this paper
• Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease.

  2002cited by this paper
• Biopharmaceutical benchmarks

  2000cited by this paper
• Asparagine-linked glycosylation in the yeast Golgi.

  1999cited by this paper
• Overview of N- and O-linked oligosaccharide structures found in various yeast species.

  1999cited by this paper
• Production of Human Compatible High Mannose-type (Man5GlcNAc2) Sugar Chains inSaccharomyces cerevisiae*

  1998cited by this paper
• Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies

  1997cited by this paper
• Cloning and analysis of the MNN4 gene required for phosphorylation of N-linked oligosaccharides in Saccharomyces cerevisiae.

  1996cited by this paper
• Structure of the N-linked oligosaccharides that show the complete loss of alpha-1,6-polymannose outer chain from och1, och1 mnn1, and och1 mnn1 alg3 mutants of Saccharomyces cerevisiae.

  1993cited by this paper
• OCH1 encodes a novel membrane bound mannosyltransferase: outer chain elongation of asparagine‐linked oligosaccharides.

  1992cited by this paper
• Structure of Saccharomyces cerevisiae alg3, sec18 mutant oligosaccharides.

  1991cited by this paper
• Control of glycoprotein synthesis. IX. A terminal Man alpha l-3Man beta 1- sequence in the substrate is the minimum requirement for UDP-N-acetyl-D-glucosamine: alpha-D-mannoside (GlcNAc to Man alpha 1-3) beta 2-N-acetylglucosaminyltransferase I.

  1984cited by this paper
• Control of glycoprotein synthesis.

  1983cited by this paper
• Control of glycoprotein synthesis. Lectin-resistant mutant containing only one of two distinct N-acetylglucosaminyltransferase activities present in wild type Chinese hamster ovary cells.

  1977cited by this paper

• Architects of folding, editors of immunity: the strategic use of N-glycans in vaccine design.

  2026cites this paper
• Expression of Tailored α-N-Acetylglucosaminidase in Escherichia coli for Synthesizing Mannose-6-Phosphate on N-Linked Oligosaccharides of Lysosomal Enzymes

  2025cites this paper
• Engineering yeast expression platforms: Advanced strategies for heterologous protein production and glycosylation modification

  2025cites this paper
• Structural deviations between native and precision fermentation-derived food proteins: techno-functionality and structure formation strategies

  2025cites this paper
• Komagataella phaffii as a microbial cell factory for antimicrobial peptide production.

  2025cites this paper
• Yeast vaccine production platform for human and animal infectious diseases

  2025cites this paper
• Novel human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in a glyco-engineered Escherichia coli strain

  2024influential citation
• Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation

  2022cites this paper
• Yeasts as Biopharmaceutical Production Platforms

  2021cites this paper
• Exploring absent protein function in yeast: assaying post translational modification and human genetic variation

  2021cites this paper
• Successive remodeling of IgG glycans using a solid-phase enzymatic platform

  2021cites this paper
• Genetic glycoengineering in mammalian cells

  2021cites this paper
• Mining Data From Plasma Cell Differentiation Identified Novel Genes for Engineering of a Yeast Antibody Factory

  2020cites this paper
• Synthetic Glycobiology: Parts, Systems, and Applications

  2020cites this paper
• Human recombinant lysosomal β‐Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay‐Sachs fibroblasts

  2020cites this paper
• Pichia pastoris—A useful experimental tool in protein engineering and production

  2020cites this paper
• Depletion of Boric Acid and Cobalt from Cultivation Media: Impact on Recombinant Protein Production with Komagataella phaffii

  2020cites this paper
• Off-target glycans encountered along the synthetic biology route towards humanized N-glycans in Pichia pastoris

  2020cites this paper
• Off‐target glycans encountered along the synthetic biology route toward humanized N‐glycans in Pichia pastoris

  2020cites this paper
• Production and Purification of Therapeutic Enzymes.

  2019cites this paper
• Therapeutic protein production in yeast is a reality in industry with an untapped potential to expand

  2019cites this paper
• Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.

  2019cites this paper
• Engineering O-glycosylation in modified N-linked oligosaccharide (Man12GlcNAc2∼Man16GlcNAc2) Pichia pastoris strains

  2019cites this paper
• Production and characterization of a human lysosomal recombinant iduronate‐2‐sulfatase produced in Pichia pastoris

  2018cites this paper
• Metabolic engineering of Pichia pastoris.

  2018cites this paper
• Glycoengineering design options for IgG1 in CHO cells using precise gene editing

  2018cites this paper
• Glycosylation control technologies for recombinant therapeutic proteins

  2018cites this paper
• Following nature's roadmap: folding factors from plasma cells led to improvements in antibody secretion in S. cerevisiae.

  2017cites this paper
• Production of Recombinant Trichoderma reesei Cellobiohydrolase II in a New Expression System Based on Wickerhamomyces anomalus

  2017cites this paper
• The effect of hypoxia on the lipidome of recombinant Pichia pastoris

  2017cites this paper
• Towards systems metabolic engineering in Pichia pastoris.

  2017cites this paper
• Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement

  2017cites this paper
• Systematic investigation into the clonal variability of the non-conventional yeast Pichia pastoris

  2017cites this paper
• Abolishment of N-glycan mannosylphosphorylation in glyco-engineered Saccharomyces cerevisiae by double disruption of MNN4 and MNN14 genes

  2017influential citation
• Review of Kluyveromyces marxianus ’ Genetic and Physiological Features

  2016cites this paper
• Analytical detection and characterization of biopharmaceutical glycosylation by MS.

  2016cites this paper
• Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris

  2016cites this paper
• Characterization of recombinant human lysosomal beta-hexosaminidases produced in the methylotrophic yeast Pichia pastoris

  2016cites this paper
• Kluyveromyces marxianus as a host for heterologous protein synthesis

  2016cites this paper
• Producción, purificación y caracterización de tres hexosaminidasas lisosomales recombinantes en pichia pastoris

  2016cites this paper
• Industrial Microorganisms: Saccharomyces cerevisiae and other Yeasts

  2016cites this paper
• Recent advances in engineering yeast for pharmaceutical protein production

  2015cites this paper
• Manipulating the glycosylation pathway in bacterial and lower eukaryotes for production of therapeutic proteins.

  2015cites this paper
• Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet-Derived Growth Factor-BB in Pichia pastoris

  2015cites this paper
• Human recombinant lysosomal enzymes produced in microorganisms.

  2015cites this paper